Display options
Cite
Boettiger DC, Law MG, Ross J, et al. Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia. J Virus Erad. 2020;6(1):11-18
Boettiger, D. C., Law, M. G., Ross, J., Huy, B. V., Heng, B., Ditangco, R., Kiertiburanakul, S., Avihingsanon, A., Cuong, D. D., Kumarasamy, N., Kamarulzaman, A., Ly, P. S., Yunihastuti, E., Parwati Merati, T., Zhang, F., Khusuwan, S., Chaiwarith, R., Lee, M. P., Sangle, S., Choi, J. Y., Ku, W. W., Tanuma, J., Ng, O. T., Sohn, A. H., Wester, C. W., Nash, D., Mugglin, C., & Pujari, S. (2020). Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia. Journal of virus eradication, 6(1), 11-18.
Boettiger, D C, et al. "Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia." Journal of virus eradication vol. 6,1 (2020): 11-18.
Boettiger DC, Law MG, Ross J, Huy BV, Heng B, Ditangco R, Kiertiburanakul S, Avihingsanon A, Cuong DD, Kumarasamy N, Kamarulzaman A, Ly PS, Yunihastuti E, Parwati Merati T, Zhang F, Khusuwan S, Chaiwarith R, Lee MP, Sangle S, Choi JY, Ku WW, Tanuma J, Ng OT, Sohn AH, Wester CW, Nash D, Mugglin C, Pujari S. Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia. J Virus Erad. 2020 Feb 20;6(1):11-18. PMID: 32175086; PMCID: PMC7043905.
Copy Download .nbib Format: NLM
Share it on

J Virus Erad. 2020 Feb 20;6(1):11-18.

Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in Asia.

Journal of virus eradication

D C Boettiger, M G Law, J Ross, B V Huy, Bsl Heng, R Ditangco, S Kiertiburanakul, A Avihingsanon, D D Cuong, N Kumarasamy, A Kamarulzaman, P S Ly, E Yunihastuti, T Parwati Merati, F Zhang, S Khusuwan, R Chaiwarith, M P Lee, S Sangle, J Y Choi, W W Ku, J Tanuma, O T Ng, A H Sohn, C W Wester, D Nash, C Mugglin, S Pujari

Affiliations

  1. Kirby Institute, UNSW Sydney, Australia.
  2. Institute for Health Policy Studies, University of California, San Francisco, USA.
  3. TREAT Asia/amfAR, The Foundation for AIDS Research, Bangkok, Thailand.
  4. National Hospital for Tropical Disease, Hanoi, Vietnam.
  5. Hospital Sungai Buloh, Kuala Lumpur, Malaysia.
  6. Research Institute for Tropical Medicine, Manila, Philippines.
  7. Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
  8. HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
  9. Bach Mai Hospital, Hanoi, Vietnam.
  10. CART Clinical Research Site, Infectious Diseases Medical Centre, Voluntary Health Services, Chennai, India.
  11. University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  12. Social Health Clinic, National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
  13. Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
  14. Udayana University and Sanglah Hospital, Denpasar, Indonesia.
  15. Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  16. Chiangrai Prachanukhor Hospital, Chiangrai, Thailand.
  17. Research Institute for Health Sciences, Chiangmai, Thailand.
  18. Queen Elizabeth Hospital, Hong Kong.
  19. BJ Government Medical College and Sassoon General Hospitals, Pune, India.
  20. Severance Hospital, Seoul, South Korea.
  21. Taipei Veterans General Hospital, Taipei, Taiwan.
  22. National Center for Global Health and Medicine, Tokyo, Japan.
  23. Tan Tock Seng Hospital, Singapore.
  24. Vanderbilt University Medical Center, Institute for Global Health, Nashville, USA.
  25. Institute for Implementation Science in Population Health, City University of New York, New York, USA.
  26. Department of Epidemiology and Biostatistics, City University of New York, New York, USA.
  27. Institute of Social and Preventative Medicine, University of Bern, Switzerland.
  28. Institute for Infectious Diseases, Pune, India.

PMID: 32175086 PMCID: PMC7043905

Abstract

OBJECTIVES: Integration of HIV and non-communicable disease services improves the quality and efficiency of care in low- and middle-income countries (LMICs). We aimed to describe current practices for the screening and management of atherosclerotic cardiovascular disease (ASCVD) among adult HIV clinics in Asia.

METHODS: Sixteen LMIC sites included in the International Epidemiology Databases to Evaluate AIDS - Asia-Pacific network were surveyed.

RESULTS: Sites were mostly (81%) based in urban public referral hospitals. Half had protocols to assess tobacco and alcohol use. Protocols for assessing physical inactivity and obesity were in place at 31% and 38% of sites, respectively. Most sites provided educational material on ASCVD risk factors (between 56% and 75% depending on risk factors). A total of 94% reported performing routine screening for hypertension, 100% for hyperlipidaemia and 88% for diabetes. Routine ASCVD risk assessment was reported by 94% of sites. Protocols for the management of hypertension, hyperlipidaemia, diabetes, high ASCVD risk and chronic ischaemic stroke were in place at 50%, 69%, 56%, 19% and 38% of sites, respectively. Blood pressure monitoring was free for patients at 69% of sites; however, most required patients to pay some or all the costs for other ASCVD-related procedures. Medications available in the clinic or within the same facility included angiotensin-converting enzyme inhibitors (81%), statins (94%) and sulphonylureas (94%).

CONCLUSION: The consistent availability of clinical screening, diagnostic testing and procedures and the availability of ASCVD medications in the Asian LMIC clinics surveyed are strengths that should be leveraged to improve the implementation of cardiovascular care protocols.

© 2019 The Authors. Journal of Virus Eradication published by Mediscript.

Keywords: Asia; HIV; atherosclerosis; cardiovascular disease; hypertension

References

  1. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9 - PubMed
  2. Clin Infect Dis. 2010 May 15;50(10):1387-96 - PubMed
  3. J Epidemiol Glob Health. 2017 Mar;7(1):5-9 - PubMed
  4. PLoS One. 2014 Mar 14;9(3):e91801 - PubMed
  5. HIV Med. 2019 Mar;20(3):183-191 - PubMed
  6. J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12 - PubMed
  7. Bull World Health Organ. 2007 Nov;85(11):880-5 - PubMed
  8. J Am Heart Assoc. 2016 Mar 24;4(3):e003411 - PubMed
  9. BMC Public Health. 2016 Sep 21;16(1):1002 - PubMed
  10. J Trop Med. 2012;2012:137460 - PubMed
  11. J Acquir Immune Defic Syndr. 2006 Sep;43(1):27-34 - PubMed
  12. Int J Epidemiol. 2007 Oct;36(5):969-76 - PubMed
  13. Circulation. 2019 Jan 8;139(2):180-191 - PubMed
  14. J Biomed Inform. 2009 Apr;42(2):377-81 - PubMed
  15. JAMA Intern Med. 2013 Apr 22;173(8):614-22 - PubMed
  16. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8 - PubMed
  17. Health Policy Plan. 2017 Nov 1;32(suppl_4):iv6-iv12 - PubMed
  18. Int J Epidemiol. 2007 Apr;36(2):294-301 - PubMed
  19. BMC Health Serv Res. 2015 Sep 23;15:408 - PubMed
  20. Trop Med Int Health. 2017 Aug;22(8):926-937 - PubMed
  21. Int J Health Plann Manage. 2014 Apr-Jun;29(2):e159-73 - PubMed
  22. BMC Infect Dis. 2017 Feb 27;17(1):174 - PubMed
  23. Int J Epidemiol. 2012 Oct;41(5):1256-64 - PubMed
  24. Bull World Health Organ. 2011 Aug 1;89(8):547-547A - PubMed
  25. Lancet. 2012 Jan 7;379(9810):47-54 - PubMed
  26. Lancet. 2014 Jul 19;384(9939):241-8 - PubMed
  27. J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12 - PubMed

Publication Types

Grant support